Published in ChemMedChem on September 23, 2015
Ligand efficiency: a useful metric for lead selection. Drug Discov Today (2004) 6.60
Kinetoplastids: related protozoan pathogens, different diseases. J Clin Invest (2008) 3.59
The biology and enzymology of protein N-myristoylation. J Biol Chem (2001) 3.14
N-myristoyltransferase inhibitors as new leads to treat sleeping sickness. Nature (2010) 2.90
Chemotherapy of human African trypanosomiasis: current and future prospects. Trends Parasitol (2003) 2.58
MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry. J Comput Aided Mol Des (1995) 2.34
Lessons learnt from assembling screening libraries for drug discovery for neglected diseases. ChemMedChem (2008) 1.94
Intramolecular hydrogen bonding in medicinal chemistry. J Med Chem (2010) 1.75
Bioisosterism: a useful strategy for molecular modification and drug design. Curr Med Chem (2005) 1.60
State of the art in African trypanosome drug discovery. Curr Top Med Chem (2011) 1.53
Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitors. J Med Chem (2011) 1.33
N-myristoyltransferase: a prospective drug target for protozoan parasites. ChemMedChem (2008) 1.33
Myristoyl-CoA:protein N-myristoyltransferase depletion in trypanosomes causes avirulence and endocytic defects. Mol Biochem Parasitol (2009) 1.28
The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes. Parasitol Today (1999) 1.26
Structure-based design of potent and selective Leishmania N-myristoyltransferase inhibitors. J Med Chem (2014) 0.95
Diverse modes of binding in structures of Leishmania major N-myristoyltransferase with selective inhibitors. IUCrJ (2014) 0.90
Investigation of trypanothione reductase as a drug target in Trypanosoma brucei. ChemMedChem (2009) 0.89